Publications by authors named "S Montalvo"
Montalvo, S, Gonzalez, MP, Dietze-Hermosa, MS, Martinez, A, Rodriguez, S, Gomez, M, Ibarra-Mejia, G, Tan, E, and Dorgo, S. Effects of different stretching modalities on the antagonist and agonist muscles on isokinetic strength and vertical jump performance in young men. J Strength Cond Res XX(X): 000-000, 2024-Exercise warm-up may include static or dynamic stretching, impacting performance differently.
View Article and Find Full Text PDFArticle Synopsis
- - This study examined the differences in sprinting mechanics between high-speed treadmill and overground conditions, focusing on how an athlete’s training level and gender influence these differences.
- - Researchers analyzed data from 40 participants, including NCAA Division 1 sprinters and recreational runners, measuring kinematic variables like stride length and frequency during sprints.
- - The results indicated that treadmill sprinting affects kinematics, with elite sprinters showing better efficiency than recreational runners, and male athletes outperforming females in stride metrics, suggesting a need for tailored sprint training.
Article Synopsis
- Eccentric exercise (ECC) is gaining popularity as it enhances muscle performance with lower metabolic demands, but its effects on vascular responses are not fully understood.
- This study analyzed the changes in blood flow patterns and endothelial shear stress (ESS) during ECC at low, moderate, and high intensities using a sample of eighteen healthy individuals.
- Findings revealed that both antegrade and retrograde ESS increased significantly according to exercise intensity, indicating that ECC could help maintain endothelial health and improve blood flow dynamics.
Purpose: Consolidative durvalumab, an anti-programmed death ligand 1 (PDL1) immune checkpoint inhibitor, administered after concurrent chemoradiation improves outcomes of patients with locally advanced non-small cell lung cancer (NSCLC) without substantially increasing toxicities. We studied a chemotherapy-free regimen of thoracic radiation therapy (RT) with concurrent and consolidative durvalumab.
Methods And Materials: This single-arm phase 2 trial enrolled patients with stage III NSCLC (regardless of tumor PDL1 expression), Eastern Cooperative Oncology Group (ECOG) performance status 0-1, adequate pulmonary function, and RT fields meeting standard organ constraints.